Health Interests

FountainView Care Center Launches Concierge Care® Personal Concierge™ Readmission Reduction Program for Patients

May 22, 2017

The First SNF in Lakewood, NJ To Offer a Transitional Care Program for Discharged Patients Lakewood, NJ (May 17, 2017) – FountainView Care Center, a New Jersey Skilled Nursing Facility and GoMo Health®, a leader in post discharge care coordination and population health management solutions, have launched the first of its kind 30-60-90 day readmission […]

Cardiometabolic Health Congress Announces New Senior Planning Committee

May 19, 2017

May 15, 2017 (Boca Raton, FL) – The Cardiometabolic Health Congress is excited to announce the members of the new Senior Planning Committee for the 2017 – 2018 CMHC educational curriculum: Drs. Deepak Bhatt, Keith Ferdinand, JoAnn Lindenfeld, and Clyde Yancy. Working in conjunction with the CMHC Chairpersons, the Senior Planning Committee will lead the […]

Improved Patient Outcomes and Financial Performance

May 18, 2017

Neither orphan drug manufacturers nor their patients with rare diseases are served well by the traditional multi-channel model of drug delivery and patient service. A new integrated model increases adherence and improves patient outcomes, which in turn leads to better financial performance for manufacturers.

Sera Prognostics Appoints Nadia Altomare as Chief Commercial Officer

May 18, 2017

Sera Prognostics Appoints Nadia Altomare as Chief Commercial Officer SALT LAKE CITY, May 17, 2017– Sera Prognostics, Inc., a women’s healthcare company, announced today that Nadia F. Altomare has joined the company as chief commercial officer. Ms. Altomare will lead all commercial activities for Sera as the company makes its groundbreaking PreTRM® test available to […]

Novartis Foundation and partners launch initiative to tackle hypertension and its root causes in low-income urban communities

May 17, 2017

Basel, May 17, 2017 – On World Hypertension Day 2017, the Novartis Foundation and its partners, including Intel Corporation, the NCD Alliance, city governments and local partners, announce the launch of Better Hearts Better Cities, an innovative initiative to address the high rates of high blood pressure (hypertension) in low-income urban communities. Rapid urbanization in […]

Actress Angela Bassett joins For Your SweetHeart™ to urge people with diabetes to know their heart disease risk — in honor of her mom

May 17, 2017

RIDGEFIELD, Conn. and INDIANAPOLIS, May 16, 2017 /PRNewswire/ — Award-winning actress Angela Bassett, along with 11 leading patient and professional organizations, is joining For Your SweetHeart™: Where diabetes and heart disease meet — a nationwide movement to raise awareness of the critical link between type 2 diabetes and heart disease, the number one killer of […]

Merck announces 2016 winners and calls for applications for the 2017 Hypertension Award to mark “World Hypertension Day”

May 17, 2017

KAMPALA, Uganda, May 17, 2017/ — Merck (www.MerckGroup.com), a leading science and technology company in healthcare, life science and performance materials, marks today World Hypertension Day with the announcement of the 2016 ‘Merck Hypertension Award’ winners and the call for applications for the 2017 Hypertension Award. The award as part of the Merck Capacity Advancement […]

iX Biopharma Launches New Supplements Business Arm

May 16, 2017

Singapore, 15 May 2017 – iX Biopharma Ltd (“the Group”) has incorporated a new wholly owned subsidiary, Entity Health Pte. Ltd. (“Entity”), to promote and market its new line of products: supplements addressing specific conditions. Entity will be the Group’s third business arm, complementing its existing pharmaceutical business and chemical analysis business. Rationale In the […]

iX Biopharma Reports Positive Results from Pharmacokinetic Study of BnoX

May 16, 2017

Singapore, 15 May 2017 – Homegrown specialty pharmaceutical company iX Biopharma Ltd. (“iX Biopharma” or, together with its subsidiaries, “the Group”) is pleased to announce the results of BUP001, a pharmacokinetic study of its novel sublingual buprenorphine wafer, BnoX. BnoX, which uses the Group’s patented sublingual drug delivery technology, WaferiX, is one of the Group’s […]

Burns & Levinson Expands Intellectual Property Practice with Addition of Three Life Sciences Partners

May 10, 2017

Boston, MA, May 10, 2017 – Burns & Levinson announced today that three highly accomplished life sciences attorneys – Daniel W. Clarke, Ph.D., Christopher R. Cowles, Ph.D., and Richard B. Emmons, Ph.D. – have joined the firm as partners in its Life Sciences and Intellectual Property (IP) Groups. Together, the team brings over three decades […]

Global Japanese Pharmaceutical Firm Selects iCardiac for Oncology Clinical Trial

May 10, 2017

iCardiac Technologies, Inc., a leading innovator and provider of central core lab services, today announced that it has been selected to work on an early phase oncology clinical trial with a Japanese pharmaceutical company. The study will utilize iCardiac’s Rapid QT service offering, which enables trial sites to make more accurate patient inclusion/exclusion decisions. Rapid […]

Implementing a Study Design Change Late in a Trial for Breast Cancer Indication

May 10, 2017

This eligibility study for a breast cancer indication began as a single-read model with six radiologists assigned. Based on the data submitted, the sponsor identified favorable results when the trial was well underway. Consequently, the sponsor sought a more robust approach, requiring a trial design change involving a double radiology read with adjudication. Now on […]

FEEDBACK